WBA Walgreens Boots Alliance

$41.98
$1.10 (2.69%)

WBA Stock Analysis Overview

What this means: InvestorsObserver gives Walgreens Boots Alliance (WBA) an overall rank of 43, which is below average. Walgreens Boots Alliance is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full WBA report

Walgreens Boots Alliance (WBA) Analyst Forecast

Next 12 months ➝Current Price$41.9852-week High$64.5052-week Low$36.65MEAN$48.31+15.07%HIGH$61.00+45.31%LOW$42.00+0.05%
  • Last Price$41.98
  • Previous Close$40.88
  • Change $1.10
  • Open$41.31
  • Volume7,901,686
  • Avg. Volume (100-day)7,409,638
  • Market Capitalization$37B
  • Days Range $41.26 - $42.33
  • 52-week Range $36.65 - $64.50
  • Dividend Yield4.36%
  • Ex. Dividend Date05/19/2020
  • P-E10.5
  • EPS3.91
  • Earnings Date07/09/2020
  • SectorConsumer Defensive
  • IndustryPharmaceutical Retailers
  • Avg. Analyst Rec.
  • Beta1.207
  • PEG Ratio2.01
  • Volatility0.39
  • Average True Range0.03
Walgreens Boots Alliance operates nearly 19,000 locations in 50 states and 25 countries. The core defensive positioning is primarily around the pharmacy that are placed in high traffic locations. Currently, the company has the largest retail pharmacy market share (around 20%, excluding mail) which provides significant cost advantages and scale. Annually, the company generates over $140 billion in revenue consisting of U.S. retail pharmacy (around 75%), International pharmacy (around 10%) and pharmaceutical wholesale (around 20%). Walgreens has established strategic partnerships to offer incremental services to increase average revenue per customer and has an equity stakes in AmerisourceBergen (26%) and Sinopharm Holding Guoda Drugstores (40%).